Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.32 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28646453 | 1.00 | SMN1; SMN2 (0.33) | SMN1; SMN2OPRK1ADAM17MAPTSIGMAR1 | |
| SCHEMBL15960839 | 0.81 | — | — | |
| SCHEMBL30590771 | 0.81 | ATM (0.43) | SMN1; SMN2OPRK1ADAM17 | |
| SCHEMBL8522492 | 0.81 | ATM (0.43) | SMN1; SMN2OPRK1ADAM17 | |
| SCHEMBL8576503 | 0.79 | — | — | |
| SCHEMBL7514666 | 0.79 | — | — | |
| SCHEMBL2888549 | 0.79 | — | — | |
| SCHEMBL19716039 | 0.79 | — | — | |
| SCHEMBL1752718 | 0.77 | — | — | |
| SCHEMBL7810859 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9595734-B2 | Non-aqueous liquid electrolyte for secondary battery and secondary battery | FUJIFILM CORPORATION (JP) | 2017-03-14 | — | — | US | disclosed |
| US-20140234729-A1 | NON-AQUEOUS LIQUID ELECTROLYTE FOR SECONDARY BATTERY AND SECONDARY BATTERY | FUJIFILM CORPORATION (JP) | 2014-08-21 | — | — | US | disclosed |
| EP-0845454-A1 | Method for the production of optically active cyclopropane derivatives | Ajinomoto Co., Inc. (JP) | 1998-06-03 | — | — | EP | disclosed |